Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (41-50 of 355) with videos related to

Pageof 36
Sort By:
Nature Cell Biology|December 6, 2022
IL-2 engineered MSCs rescue T cells in tumoursMelita Irving, Yaquelin Ortiz-Miranda, George Coukos
Journal of Translational Medicine|May 1, 2008
Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cellsFabian Benencia, Maria C Courrèges, George Coukos
Revue Medicale Suisse|July 19, 2016
[Not Available]Pierre-Yves Dietrich, George Coukos, Matti Aapro
Hepatology (Baltimore, Md.)|August 23, 2012
TIE2-expressing monocytes: a novel cellular biomarker for hepatocellular carcinoma?Michele De Palma, George Coukos, David Semela
Seminars in Immunology|April 2, 2010
Whole tumor antigen vaccinesCheryl Lai-Lai Chiang, Fabian Benencia, George Coukos
Revue Medicale Suisse|July 19, 2016
[Principles of adoptive cell therapy based on "Tumor Infiltrating Lymphocytes"]Filipe Martins, Angela Orcurto, Olivier Michielin, et al.
Nature Reviews. Drug Discovery|February 3, 2025
Novel strategies to manage CAR-T cell toxicityArthur Mulvey, Lionel Trueb, George Coukos, et al.
Seminars in Immunology|March 22, 2016
TCR-engineered T cells to treat tumors: Seeing but not touching?Reno Debets, Emmanuel Donnadieu, Salem Chouaib, et al.
Expert Opinion on Medical Diagnostics|March 19, 2013
Expression profile of microRNA in epithelial cancer: diagnosis, classification and predictionShan Deng, Jinghe Lang, George Coukos, et al.
The AAPS Journal|October 31, 2009
Therapeutic microRNA strategies in human cancerChunsheng Li, Yi Feng, George Coukos, et al.
Pageof 36

Showing results (41-50 of 355) with videos related to

Sort By:
Pageof 36
Nature Cell Biology|December 6, 2022
IL-2 engineered MSCs rescue T cells in tumoursMelita Irving, Yaquelin Ortiz-Miranda, George Coukos
Journal of Translational Medicine|May 1, 2008
Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cellsFabian Benencia, Maria C Courrèges, George Coukos
Revue Medicale Suisse|July 19, 2016
[Not Available]Pierre-Yves Dietrich, George Coukos, Matti Aapro
Hepatology (Baltimore, Md.)|August 23, 2012
TIE2-expressing monocytes: a novel cellular biomarker for hepatocellular carcinoma?Michele De Palma, George Coukos, David Semela
Seminars in Immunology|April 2, 2010
Whole tumor antigen vaccinesCheryl Lai-Lai Chiang, Fabian Benencia, George Coukos
Revue Medicale Suisse|July 19, 2016
[Principles of adoptive cell therapy based on "Tumor Infiltrating Lymphocytes"]Filipe Martins, Angela Orcurto, Olivier Michielin, et al.
Nature Reviews. Drug Discovery|February 3, 2025
Novel strategies to manage CAR-T cell toxicityArthur Mulvey, Lionel Trueb, George Coukos, et al.
Seminars in Immunology|March 22, 2016
TCR-engineered T cells to treat tumors: Seeing but not touching?Reno Debets, Emmanuel Donnadieu, Salem Chouaib, et al.
Expert Opinion on Medical Diagnostics|March 19, 2013
Expression profile of microRNA in epithelial cancer: diagnosis, classification and predictionShan Deng, Jinghe Lang, George Coukos, et al.
The AAPS Journal|October 31, 2009
Therapeutic microRNA strategies in human cancerChunsheng Li, Yi Feng, George Coukos, et al.
Pageof 36